FI894220A0 - Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö - Google Patents

Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö

Info

Publication number
FI894220A0
FI894220A0 FI894220A FI894220A FI894220A0 FI 894220 A0 FI894220 A0 FI 894220A0 FI 894220 A FI894220 A FI 894220A FI 894220 A FI894220 A FI 894220A FI 894220 A0 FI894220 A0 FI 894220A0
Authority
FI
Finland
Prior art keywords
preparation
recognition factor
general cancer
associated scm
scm recognition
Prior art date
Application number
FI894220A
Other languages
English (en)
Swedish (sv)
Other versions
FI92832B (fi
FI92832C (fi
Inventor
Boris Cercek
Lea Cercek
Original Assignee
Boris Cercek
Lea Cercek
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boris Cercek, Lea Cercek filed Critical Boris Cercek
Publication of FI894220A0 publication Critical patent/FI894220A0/fi
Publication of FI92832B publication Critical patent/FI92832B/fi
Application granted granted Critical
Publication of FI92832C publication Critical patent/FI92832C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6845Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a cytokine, e.g. growth factors, VEGF, TNF, a lymphokine or an interferon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4745Cancer-associated SCM-recognition factor, CRISPP
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI894220A 1987-03-06 1989-09-06 Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö FI92832C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US2275987A 1987-03-06 1987-03-06
US2275987 1987-03-06
PCT/US1988/000568 WO1988006595A1 (en) 1987-03-06 1988-03-04 General cancer-associated scm-recognition factor, preparation and method of use
US8800568 1988-03-04

Publications (3)

Publication Number Publication Date
FI894220A0 true FI894220A0 (fi) 1989-09-06
FI92832B FI92832B (fi) 1994-09-30
FI92832C FI92832C (fi) 1995-01-10

Family

ID=21811282

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894220A FI92832C (fi) 1987-03-06 1989-09-06 Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö

Country Status (10)

Country Link
EP (1) EP0357637B1 (fi)
KR (1) KR890700605A (fi)
AU (1) AU624071B2 (fi)
CA (1) CA1336404C (fi)
DE (1) DE3872235T2 (fi)
DK (1) DK616188D0 (fi)
FI (1) FI92832C (fi)
IL (1) IL85645A0 (fi)
NO (1) NO177596C (fi)
WO (1) WO1988006595A1 (fi)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5580561A (en) * 1987-03-06 1996-12-03 Cercek; Boris Methods and pharmaceutical compositions for blocking suppression of immune defense mechanisms using an antibody, a factor, or an antisense peptide
US5516643A (en) * 1987-03-06 1996-05-14 Cercek; Boris Immunochemical assays for cancer-associated SCM-recognition factor
US5270171A (en) * 1987-03-06 1993-12-14 Boris Cercek Cancer-associated SCM-recognition factor, preparation and method of use
EP0407451A1 (en) * 1988-03-11 1991-01-16 CERCEK, Boris General cancer-associated scm-recognition factor, preparation and method of use

Also Published As

Publication number Publication date
AU624071B2 (en) 1992-06-04
DE3872235T2 (de) 1992-12-03
FI92832B (fi) 1994-09-30
NO884919D0 (no) 1988-11-04
NO177596C (no) 1995-10-18
DK616188A (da) 1988-11-04
FI92832C (fi) 1995-01-10
DE3872235D1 (de) 1992-07-23
IL85645A0 (en) 1988-08-31
KR890700605A (ko) 1989-04-26
DK616188D0 (da) 1988-11-04
CA1336404C (en) 1995-07-25
EP0357637A1 (en) 1990-03-14
NO884919L (no) 1989-01-05
EP0357637B1 (en) 1992-06-17
NO177596B (no) 1995-07-10
AU1595188A (en) 1988-09-26
WO1988006595A1 (en) 1988-09-07

Similar Documents

Publication Publication Date Title
FI100104B (fi) Metallikompleksiyhdisteitä, menetelmä niiden valmistamiseksi ja käyttö menetelmä
DE3779685D1 (de) Abgabebehaelter.
DE3781548D1 (de) Verfahren zur verdichtung von materialvorformen.
GB8600349D0 (en) Ejector pumps
FI96961B (fi) Biorientoitu kalvo, menetelmä sen valmistamiseksi ja sen käyttö
EP0188388A3 (en) Alpha-alumina particles, and process for preparing the same
FI77057B (fi) Foerfarande foer framstaellning av roer, staenger och band.
DE59006970D1 (de) Verfahren zur Herstellung von Polyetherglykolen.
FI885765A0 (fi) Itsekantava erittäin luja termoplastinen luunkorjausväline ja menetelmä sen valmistamiseksi
DE68908614D1 (de) Vorrichtung zur Herstellung von gebogenen Glasscheiben.
DE3779774D1 (de) Extraktionsverfahren mit ueberkritischem gas.
FI892058A0 (fi) Fenolin valmistusmenetelmä
FI880020A0 (fi) Vaesentigen ren cytotoxitet utloesande faktor.
EP0228701A3 (en) 2-iodo-perfluoro-2-methylathanes, process for their production and their application
DE3783325D1 (de) Lackierverfahren.
FI885692A (fi) Karboksimetyylisulfoetyyliselluloosa ja menetelmä sen valmistamiseksi
DE3371199D1 (en) Novel 6-nitroprostaglandin derivatives, process for production thereof, and use thereof
FI894220A0 (fi) Yleinen syöpään liittyvä SCM-tunnistustekijä, menetelmä sen valmistamiseksi ja sen käyttö
ZA876305B (en) 3-perfluoroalkyl-5-substituted-oxy-isoxazole derivatives,process for preparing the same,and herbicides containing the same
EP0243607A3 (en) Process for manufacturing bicarbamates, and new bicarbamates
FI910677A0 (fi) Process och anordning foer framstaellning av tryckplattor.
ZA872721B (en) Compound,process and use
FI870787A0 (fi) Renad human angiogen faktor, foerfarande foer dess framstaellning och farmaceutiska kompositioner.
DE3675631D1 (de) In-vitro-kulturverfahren.
FI883133A (fi) Installering och montering av roer.

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed
MM Patent lapsed

Owner name: CERCEK, BORIS